C4 Therapeutics Inc
CCCC2.230USD
+0.240+12.06%
Close 07/11, 16:00（ET）Quotes delayed by 15 min
2.230USD+2.230After-hours (ET)
158.31MMarket Cap
LossP/E TTM
C4 Therapeutics Inc
2.230
+0.240+12.06%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Total revenue
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
--9.78M
--7.43M
--8.26M
--8.45M
Revenue
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
--9.78M
--7.43M
--8.26M
--8.45M
Operating expenses
10.91%36.40M
5.40%42.89M
12.16%43.61M
-16.86%33.45M
-17.92%32.82M
-1.12%40.69M
-0.92%38.88M
-2.39%40.23M
2.47%39.99M
16.45%41.15M
19.81%39.24M
29.22%41.22M
39.69%39.02M
30.07%35.33M
22.23%32.75M
--31.90M
--27.93M
--27.16M
--26.80M
R&D expenses
20.14%27.07M
6.98%32.51M
12.32%31.84M
-20.63%23.75M
-22.41%22.53M
-0.85%30.39M
-4.44%28.35M
-4.46%29.93M
10.83%29.04M
15.45%30.65M
22.06%29.66M
34.51%31.32M
27.66%26.20M
29.94%26.55M
4.14%24.30M
--23.29M
--20.53M
--20.43M
--23.34M
Depreciation, depletion, and amortization
1.79%456.00K
11.63%480.00K
-1.12%442.00K
-2.18%448.00K
-17.80%448.00K
-17.47%430.00K
7.71%447.00K
5.29%458.00K
78.69%545.00K
61.30%521.00K
25.76%415.00K
12.11%435.00K
-32.37%305.00K
-11.51%323.00K
-45.00%330.00K
--388.00K
--451.00K
--365.00K
--600.00K
Operating profit
2.08%-29.16M
-0.75%-37.71M
-1.57%-28.24M
42.92%-21.44M
17.79%-29.78M
2.26%-37.43M
14.41%-27.81M
-37.19%-37.57M
-15.49%-36.23M
-151.02%-38.29M
-33.95%-32.49M
-23.82%-27.38M
-52.95%-31.37M
19.30%-15.26M
-32.18%-24.25M
---22.12M
---20.51M
---18.90M
---18.35M
Net non-operating interest income (expenses)
Non-operating interest income
-26.33%2.84M
10.75%3.27M
39.66%3.58M
65.89%3.73M
87.83%3.86M
72.62%2.95M
136.35%2.56M
343.87%2.25M
644.20%2.05M
1156.62%1.71M
885.45%1.08M
633.33%506.00K
283.33%276.00K
-78.14%136.00K
--110.00K
--69.00K
--72.00K
--622.00K
----
Non-operating interest expense
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-69.86%167.00K
12.36%600.00K
14.99%606.00K
11.50%601.00K
2.78%554.00K
0.19%534.00K
-1.31%527.00K
-49.10%539.00K
--539.00K
--533.00K
--534.00K
--1.06M
----
Special income (expenses)
100.00%0.00
--0.00
100.00%0.00
--0.00
---2.44M
--0.00
---621.00K
----
----
----
----
----
----
100.00%0.00
100.00%0.00
----
----
---2.54M
---3.14M
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---44.00K
---160.00K
Income before tax
7.19%-26.32M
0.10%-34.44M
5.25%-24.67M
50.68%-17.72M
18.46%-28.36M
7.28%-34.48M
18.54%-26.03M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
28.56%-15.66M
-12.19%-24.68M
---22.58M
---20.97M
---21.92M
---22.00M
Income tax
--0.00
-52.71%131.00K
-100.00%0.00
----
----
--277.00K
--1.00M
----
----
----
----
----
--0.00
100.00%0.00
100.00%0.00
--0.00
--0.00
---124.00K
---167.00K
Income after tax
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
28.16%-15.66M
-13.04%-24.68M
---22.58M
---20.97M
---21.80M
---21.84M
Net income from continuous operations
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
28.16%-15.66M
-13.04%-24.68M
---22.58M
---20.97M
---21.80M
---21.84M
Net income attributable to controlling interests
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
---22.58M
---20.97M
---11.43M
---27.05M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
--0.00
----
--5.21M
Net income attributable to common shareholders
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
---22.58M
---20.97M
---11.43M
---27.05M
Basic earnings per share
10.33%-0.37
27.80%-0.49
35.52%-0.35
64.84%-0.26
41.57%-0.41
10.71%-0.68
15.90%-0.55
-30.40%-0.73
-9.33%-0.71
-136.09%-0.76
-28.33%-0.65
-9.05%-0.56
-33.30%-0.65
-21.16%-0.32
21.81%-0.51
---0.51
---0.49
---0.27
---0.65
Diluted earnings per share
10.33%-0.37
27.80%-0.49
35.52%-0.35
64.84%-0.26
41.57%-0.41
10.71%-0.68
15.90%-0.55
-30.40%-0.73
-9.33%-0.71
-136.09%-0.76
-28.33%-0.65
-9.05%-0.56
-33.30%-0.65
-21.16%-0.32
21.81%-0.51
---0.51
---0.49
---0.27
---0.65
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
